SEARCH
Search Details
KATAYAMA YoshioUniversity Hospital / HematologyAssociate Professor
Researcher basic information
■ Research news- 18 Jan. 2021, FGF23 hormone from red blood cell precursors promotes hematopoietic stem cell mobilization
- 08 Feb. 2019, Vitamin D and immune cells stimulate bone marrow disease
- 24 Nov. 2016, Mechanism revealed for side effects of drug used in hematopoietic stem cell harvesting
■ Research Areas
■ Committee History
Research activity information
■ Paper- Despite the importance of lipid mediators in stress and depression and their link to inflammation, the influence of stress on these mediators and their role in inflammation is not fully understood. This study used RNA-seq, LC-MS/MS, and flow cytometry analyses in a mouse model subjected to chronic social defeat stress to explore the effects of acute and chronic stress on lipid mediators, gene expression, and cell population in the bone marrow and spleen. In the bone marrow, chronic stress induced a sustained transition from lymphoid to myeloid cells, accompanied by corresponding changes in gene expression. This change was associated with decreased levels of 15-deoxy-d12,14-prostaglandin J2, a lipid mediator that inhibits inflammation. In the spleen, chronic stress also induced a lymphoid-to-myeloid transition, albeit transiently, alongside gene expression changes indicative of extramedullary hematopoiesis. These changes were linked to lower levels of 12-HEPE and resolvins, both critical for inhibiting and resolving inflammation. Our findings highlight the significant role of anti-inflammatory and pro-resolving lipid mediators in the immune responses induced by chronic stress in the bone marrow and spleen. This study paves the way for understanding how these lipid mediators contribute to the immune mechanisms of stress and depression.Apr. 2024, Journal of pharmacological sciences, 154(4) (4), 279 - 293, English, Domestic magazineScientific journal
- The relationship between bone tissue and bone marrow, which is responsible for hematopoiesis, is inseparable. Osteoblasts and osteocytes, which produce and consist of bone tissue, regulate the function of hematopoietic stem cells (HSC), the ancestors of all hematopoietic cells in the bone marrow. The peripheral nervous system finely regulates bone remodeling in bone tissue and modulates HSC function within the bone marrow, either directly or indirectly via modification of the HSC niche function. Peripheral nerve signals also play an important role in the development and progression of malignant tumors (including hematopoietic tumors) and normal tissues, and peripheral nerve control is emerging as a potential new therapeutic target. In this review, we summarize recent findings on the linkage among blood system, bone tissue, and peripheral nerves.Feb. 2023, Journal of bone and mineral metabolism, English, Domestic magazineScientific journal
- Japanese Pharmacological Society, 2023, Proceedings for Annual Meeting of The Japanese Pharmacological Society, 97, 3 - BScientific journal
- Loss of TFL, found in several types of lymphoma, induces excessive CXCL13 secretion through RNA dysregulation contributing to body weight loss and early death in lymphoma model mice. Follicular lymphoma (FL) is associated with overexpressed BCL-2 and other genetic aberrations, including 6q-. We identified a novel gene on 6q25, "Transformed follicular lymphoma (TFL)," from a transformed FL. TFL regulates several cytokines via mRNA degradation, which has been suggested to underlie resolving inflammation. Fluorescence in situ hybridization revealed a deletion of TFL occurred in 13.6% of various B-cell lymphoma samples. We developed VavP-bcl2 transgenic, TFL deficit mice (Bcl2-Tg/Tfl -/-) to seek how TFL affects disease progression in this lymphoma model. While Bcl2-Tg mice developed lymphadenopathy and died around 50 weeks, Bcl2-Tg/Tfl -/- mice lost body weight around 30 weeks and died about 20 weeks earlier than Bcl2-Tg mice. Furthermore, we found a unique B220-IgM+ cell population in the bone marrow of Bcl2-Tg mice. cDNA array in this population revealed that Cxcl13 mRNA in Bcl2-Tg/Tfl -/- mice expressed significantly higher than Bcl2-Tg mice. In addition, bone marrow extracellular fluid and serum showed an extremely high Cxcl13 concentration in Bcl2-Tg/Tfl -/- mice. Among bone marrow cells, the B220-IgM+ fraction was the main producer of Cxcl13 in culture. A reporter assay demonstrated TFL regulates CXCL-13 via induction of 3'UTR mRNA degradation in B lineage cells. These data suggest Tfl regulates Cxcl13 in B220-IgM+ cells in the bone marrow, and a very high concentration of serum Cxcl13 arising from these cells may contribute to early death in lymphoma-bearing mice. Since several reports have suggested the association of CXCL13 expression with lymphoma, these findings provide new insights into cytokine regulation via TFL in lymphoma.2023, Frontiers in immunology, 14, 1197112 - 1197112, English, International magazineScientific journal
- Fibroblast growth factor 23 (FGF-23) hormone is produced by bone-embedded osteocytes and regulates phosphate homeostasis in kidneys. We found that administration of granulocyte colony-stimulating factor (G-CSF) to mice induced a rapid, substantial increase in FGF-23 messenger RNA in bone marrow (BM) cells. This increase originated mainly from CD45-Ter119+CD71+ erythroblasts. FGF-23 protein in BM extracellular fluid was markedly increased during G-CSF-induced hematopoietic progenitor cell (HPC) mobilization, but remained stable in the blood, with no change in the phosphate level. Consistent with the BM hypoxia induced by G-CSF, low oxygen concentration induced FGF-23 release from human erythroblast HUDEP-2 cells in vitro. The efficient mobilization induced by G-CSF decreased drastically in both FGF-23-/- and chimeric mice with FGF-23 deficiency, only in hematopoietic cells, but increased in osteocyte-specific FGF-23-/- mice. This finding suggests that erythroblast-derived, but not bone-derived, FGF-23 is needed to release HPCs from BM into the circulation. Mechanistically, FGF-23 did not influence CXCL-12 binding to CXCR-4 on progenitors but interfered with their transwell migration toward CXCL-12, which was canceled by FGF receptor inhibitors. These results suggest that BM erythroblasts facilitate G-CSF-induced HPC mobilization via FGF-23 production as an intrinsic suppressor of chemoattraction.Corresponding, Mar. 2021, Blood, 137(11) (11), 1457 - 1467, English, International magazine[Refereed]Scientific journal
- The mobilization efficiency of hematopoietic stem/progenitor cells from bone marrow (BM) to circulation by granulocyte colony-stimulating factor (G-CSF) is dramatically dispersed in humans and mice with no mechanistic lead for poor mobilizers. The regulatory mechanism for mobilization efficiency by dietary fat was assessed in mice. Fat-free diet (FFD) for 2 weeks greatly increased mobilization compared to normal diet (ND). The BM mRNA level of peroxisome proliferator-activated receptor δ (PPARδ), a receptor for lipid mediators, was markedly up-regulated by G-CSF in mice fed with ND and displayed strong positive correlation with widely scattered mobilization efficiency. It was hypothesized that BM fat ligand for PPARδ might inhibit mobilization. The PPARδ agonist inhibited mobilization in mice fed with ND and enhanced mobilization by FFD. Treatment with the PPARδ antagonist and chimeric mice with PPARδ+/- BM showed enhanced mobilization. Immunohistochemical staining and flow cytometry revealed that BM PPARδ expression was enhanced by G-CSF mainly in mature/immature neutrophils. BM lipid mediator analysis revealed that G-CSF treatment and FFD resulted in the exhaustion of ω3-polyunsaturated fatty acids such as eicosapentaenoic acid (EPA). EPA induced the up-regulation of genes downstream of PPARδ, such as carnitine palmitoyltransferase-1α and angiopoietin-like protein 4 (Angptl4), in mature/immature neutrophils in vitro and inhibited enhanced mobilization in mice fed with FFD in vivo. Treatment of wild-type mice with the anti-Angptl4 antibody enhanced mobilization together with BM vascular permeability. Collectively, PPARδ signaling in BM mature/immature neutrophils induced by dietary fatty acids negatively regulates mobilization, at least partially, via Angptl4 production.Corresponding, Feb. 2021, Haematologica, 106(6) (6), 1671 - 1683, English, International magazine, Co-authored internationally[Refereed]Scientific journal
- BACKGROUND AND PURPOSE: Inflammation has been associated with stress-related mental disturbances. Rodent studies have reported that blood-borne cytokines are crucial for stress-induced changes in emotional behaviours. However, the roles and regulation of leukocytes in chronic stress remain unclear. EXPERIMENTAL APPROACH: Adult male C57BL/6N mice were subjected to repeated social defeat stress (R-SDS) with two protocols which differed in stress durations, stress cycles, and housing conditions, followed by the social interaction test. The numbers of leukocyte subsets in the bone marrow, spleen, and blood were determined by flow cytometry shortly after or several days after R-SDS. These leukocyte changes were studied in two strains of mice with different stress susceptibility, C57BL/6N and BALB/c mice. KEY RESULTS: R-SDS with both protocols similarly induced social avoidance in C57BL/6N mice. In the bone marrow, neutrophils and monocytes were increased, and T cells, B cells, NK cells, and dendritic cells were decreased with both protocols. In the blood, neutrophils and monocytes were increased with both protocols, whereas T cells, B cells, NK cells, and dendritic cells were decreased with one of these. Neutrophils and monocytes were also increased in the spleen. Changes in the bone marrow and increased levels of circulating neutrophils were maintained for 6 days after R-SDS. BALB/c mice showed greater social avoidance and increase in circulating neutrophils than C57BL/6N mice. CONCLUSION AND IMPLICATIONS: In two strains of mice, chronic stress induced neutrophil mobilization and its maintenance. These effects were strain-related and may contribute to the pathology of mental illness. LINKED ARTICLES: This article is part of a themed issue on Neurochemistry in Japan. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.4/issuetoc.Feb. 2021, British journal of pharmacology, 178(4) (4), 827 - 844, English, International magazineScientific journal
- Mammals have developed bone marrow (BM) inside the bone tissue because of evolution. Now, it appears that bone tissue displays functional communication with the hematopoietic system. Osteoblast lineage cells serve as a part of the microenvironment for immature hematopoietic cells, whereas mature hematopoietic cells play important roles in regulating osteoblast activity. The nervous system maintains the balance between the hematopoietic and skeletal systems. An understanding of the multiple-organ network that exists between the BM and other systems is useful to elucidate phenomena in clinical hematology and even in other fields, an area which I propose to call "marrowlogy."2020, [Rinsho ketsueki] The Japanese journal of clinical hematology, 61(9) (9), 1058 - 1063, Japanese, Domestic magazineScientific journal
- (一社)日本検査血液学会, Jun. 2019, 日本検査血液学会雑誌, 20(学術集会) (学術集会), S192 - S192, JapanesePTクロスミキシング試験が有用であった後天性第V因子インヒビターの一症例[Refereed]
- Sinusoidal obstruction syndrome (SOS) is a lethal complication after hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is the only drug internationally recommended for SOS treatment in Western countries. Recombinant human soluble thrombomodulin (rhTM), which is promising for the treatment of patients with disseminated intravascular coagulation, is also reported to be potentially effective for SOS. To clarify the safety and efficacy of DF and rhTM, we conducted a retrospective survey of these agents in Japan. Data from 65 patients who underwent allogeneic HSCT and received DF (n = 24) or rhTM (n = 41) for SOS treatment were collected. The complete response rates for SOS on day 100 were 50% and 54% in the DF and rhTM groups, respectively. The 100-day overall survival rates were 50% in the DF group, and 48% in the rhTM group. Several severe hemorrhagic adverse events were observed in one patient in the DF group and five patients in the rhTM group. The main causes of death were SOS-related death, and no patient died of direct adverse events of DF or rhTM. Our results suggest that rhTM, as well as DF, can be effective as a novel treatment option for SOS.May 2019, Bone marrow transplantation, 54(5) (5), 674 - 680, English, International magazine[Refereed]Scientific journal
- Myelofibrosis in myeloproliferative neoplasms (MPNs) with mutations such as JAK2V617F is an unfavorable sign for uncontrollable disease progression in the clinic and is complicated with osteosclerosis whose pathogenesis is largely unknown. Because several studies have revealed that macrophages are an indispensable supporter for bone-forming osteoblasts, we speculated that macrophages might play a significant role in the proliferation of collagen-producing myofibroblasts in marrow fibrotic tissues. Here, we show that myelofibrosis critically depends on macrophages whose differentiation is skewed by vitamin D receptor (VDR) signaling. In our novel myelofibrosis model established by transplantation of VDR+/+ hematopoietic stem/progenitor cells into VDR-/- mice, donor-derived F4/80+ macrophages proliferated together with recipient-derived α-smooth muscle actin-positive myofibroblasts, both of which comprised fibrotic tissues with an indistinguishable spindle-shaped morphology. Interfering VDR signals, such as low vitamin D diet and VDR deficiency in donor cells as well as macrophage depletion prevented myelofibrosis in this model. These interventions also ameliorated myelofibrosis in JAK2V617F-driven murine MPNs likely in a transforming growth factor-β1- or megakaryocyte-independent manner. These results suggest that VDR and macrophages may be novel therapeutic targets for MPNs with myelofibrosis.Apr. 2019, Blood, 133(15) (15), 1619 - 1629, English, International magazine[Refereed]Scientific journal
- Background: Transformed follicular lymphoma (TFL, ZC3H12D) was identified as a candidate tumor suppressor gene that contributes to cell-cycle arrest through regulation of Rb phosphorylation, but the clinical impact of TFL is unknown. The goal of this study was to evaluate the prognostic significance of TFL expression in advanced endometrial cancer.Methods: Tissue samples were obtained from 103 patients with Federation Internationale des Gynaecologistes et Obstetristes stage III-IV endometrial cancer. Associations between TFL expression and outcomes were evaluated using the Kaplan-Meier method and multivariate Cox proportional hazards regression models.Results: There were 24 TFL-low cases (23.3%) and the 10-year progression-free survival (PFS) and overall survival (OS) in these cases were lower than those for patients with normal TFL expression in univariate analysis (PFS, P = 0.003; OS, P = 0.106). In multivariate analysis, TFL status was a significant predictor for PFS [HR = 2.76; 95% confidence interval (CI), 1.45-5.28; P = 0.002] and OS (HR = 1.94; 95% CI, 0.91-4.11; P = 0.085), adjusted for covariates. The TFL gene maps to human chromosome 6q25.1, where estrogen receptor alpha (ERα) gene ESR1 is also located. Lack of ERα expression is a poor prognostic factor in early endometrial cancer. Among 41 ERα-low patients, 10-year PFS was significantly lower in 15 TFL-low cases (univariate analysis, P = 0.055; multivariate analysis, HR = 4.70; 95% CI, 1.68-13.20; P = 0.003).Conclusions: We identified TFL as a strong independent prognostic factor, regardless of ERα status.Impact: An investigation of the mechanism underlying tumor suppression by TFL may lead to new therapies for patients with advanced endometrial cancer. Cancer Epidemiol Biomarkers Prev; 27(8); 963-9. ©2018 AACR.Aug. 2018, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 27(8) (8), 963 - 969, English, International magazine[Refereed]Scientific journal
- (一社)日本検査血液学会, Jun. 2018, 日本検査血液学会雑誌, 19(学術集会) (学術集会), S182 - S182, Japanese慢性好塩基球性白血病から急性骨髄性白血病へと進展した一症例[Refereed]Research society
- Jun. 2018, 皮膚病診療, 40(6) (6), 587 - 590, Japanese【色素沈着を伴う皮膚病】 <臨床例>トシリズマブによる長期間の治療効果を観察しえた多中心性Castleman病に伴う皮膚形質細胞増多症[Refereed]Scientific journal
- Medical Journals/Acta D-V, Feb. 2018, Acta dermato-venereologica, 98(2) (2), 275 - 277, English, International magazine[Refereed]Scientific journal
- 日本皮膚科学会-大阪地方会・京滋地方会, Dec. 2017, 皮膚の科学, 16(6) (6), 442 - 443, Japanese骨髄異形成症候群の経過中に遊走性血栓性静脈炎を合併した1例
- Dec. 2017, Neurosurgical Emergency, 22(2号) (2号), 128 - 134, Japaneseペランパネルで対処したNCSE非痙攣性てんかん重積発作の1例[Refereed]Scientific journal
- May 2017, 臨床血液, 58(5) (5), 425, JapanesePicture in Clinical Hematology(No.103) Cilostazol-induced pure white cell aplasia(図説)[Refereed]Scientific journal
- Apr. 2017, International journal of hematology, 105(4) (4), 485 - 496, English, Domestic magazine[Refereed]Scientific journal
- Feb. 2017, Blood, 129(5) (5), 587 - 597, English, International magazine[Refereed]Scientific journal
- (一社)日本透析医学会, 2016, 日本透析医学会誌, 49(12) (12), 847 - 852, Japanese[Refereed]Scientific journal
- Blackwell Publishing Ltd, Oct. 2015, Transplant International, 28(10) (10), 1245 - 1250, English[Refereed]Scientific journal
- Aug. 2015, CURRENT OSTEOPOROSIS REPORTS, 13(4) (4), 193 - 197, English[Refereed]Scientific journal
- Jun. 2015, Bone Marrow Transplantation, 50(6) (6), 870 - 872, English[Refereed]Scientific journal
- Sep. 2014, ANNALS OF HEMATOLOGY, 93(9) (9), 1609 - 1610, English[Refereed]Scientific journal
- We report two patients (70- and 49-year-old Japanese men) with acute exacerbation of chronic idiopathic thrombocytopenic purpura (ITP) and deep venous thrombosis of the lower extremities. Both were successfully managed with thrombopoietin receptor agonist (TPO-RA) administration. Both had ITP refractory to steroid treatment. Their immature platelet fraction (absolute-IPF) counts were increased and paralleled the platelet recoveries after TPO-RA (eltrombopag and romiplostim, respectively) without progression of thrombosis. Although ITP has recently been evaluated as a thrombophilic disorder, reports on acute exacerbation of ITP with newly diagnosed thrombosis are limited, and the pathophysiology and association between ITP and thrombosis remain to be elucidated. Moreover, the influences of TPO-RA on thrombosis are still controversial. To our knowledge, this is the first case report describing patients with exacerbation of ITP who developed thrombosis and were treated with TPO-RA. The outcomes of our cases underscore the importance of monitoring thrombosis and not delaying the initiation of anticoagulation treatment during the use of TPO-RA.6, Jun. 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55(6) (6), 697 - 702, Japanese, Domestic magazine[Refereed]Scientific journal
- Jun. 2014, 臨床血液, 55(6号) (6号), 697 - 702, JapaneseTPO受容体作動薬を使用し抗凝固療法への移行が可能であった下肢深部静脈血栓症合併慢性ITP急性増悪[Refereed]Scientific journal
- May 2014, ANNALS OF HEMATOLOGY, 93(5) (5), 897 - 898, English[Refereed]Scientific journal
- May 2014, EXPERIMENTAL HEMATOLOGY, 42(5) (5), 369 - 379, English[Refereed]Scientific journal
- Apr. 2014, EUROPEAN JOURNAL OF HAEMATOLOGY, 92(4) (4), 362 - 364, English[Refereed]Scientific journal
- Feb. 2014, JOURNAL OF IMMUNOLOGY, 192(4) (4), 1512 - 1524, English[Refereed]Scientific journal
- Nov. 2013, CELL METABOLISM, 18(5) (5), 749 - 758, English[Refereed]Scientific journal
- Sep. 2013, Blood Coagulation and Fibrinolysis, 24(6) (6), 638 - 641, English[Refereed]Scientific journal
- Jun. 2013, CELL STEM CELL, 12(6) (6), 737 - 747, English[Refereed]Scientific journal
- Lenalidomide treatment for refractory or relapsed multiple myeloma in elderly patients may be feasible in an outpatient setting. However, difficulties have been associated with the management of adverse effects. Therefore, a dose reduction in lenalidomide has been recommended in some cases. In this report, we encountered the successful treatment of myeloma in 6 elderly patients (aged above 70 years) with very low-dose lenalidomide (5 mg daily). Four patients exhibited more than a partial response with an 8.6 months median follow-up period, which was comparable with previous findings. The major adverse effect observed was infection, which occurred during the first several cycles. Others were less toxic, especially the absence of grade 3/4 toxicities for hematological adverse effects.The Japanese Society of Hematology, 2013, 臨床血液, 54(5) (5), 457 - 462, Japanese
Although a dose reduction in lenalidomide therapy for elderly patients is controversial, a very low dose could be safe and effective. Our group is currently conducting a multi-center prospective trial to evaluate the efficacy of low-dose lenalidomide therapy.[Refereed]Scientific journal - 2013, J Clin Exp Hematop, 53(3) (3), 207 - 13, EnglishEosinophilia and bone lesion as clinical manifestations of aggressive systemic mastocytosis[Refereed]Scientific journal
- Jun. 2012, EUROPEAN JOURNAL OF IMMUNOLOGY, 42(6) (6), 1562 - 1572, English[Refereed]Scientific journal
- 2012, [Rinshō ketsueki] The Japanese journal of clinical hematology, 53(8) (8), 785 - 787, English[Diminished expression of CD5 and/or CD7 surface antigens as the first clue of diagnosis for monoclonal T lymphocytosis].Scientific journal
- To know the real figure of hematopoietic stem cell donation for further development of donors safety and satisfaction, we analyzed family donors opinions which were collected through nation-wide family donor annual follow up system conducted by Japan Society for Hematopoietic Cell Transplantation (JSHCT) between April , 2006 and March, 2010. The outcomes were then compared between bone marrow (BM) donors and peripheral blood stem cell (PBSC) donors. The ratio of satisfaction (dissatisfaction) after the donation was not different between BM and PBSC donors nevertheless, physical complaints with dissatisfaction were significantly higher among BM donors. Major physical complaint was pain, especially unexpectedly prolonged pain due to marrow aspiration which was assumed to be improved by the development of harvest techniques, of devices such as the size of needles and by further concerns of harvest teams to donors.The Japan Society for Hematopoietic Stem Cell Transplantation, 2012, 日本造血細胞移植学会雑誌, 1(1) (1), 6 - 14, Japanese[Refereed]Scientific journal
- 2012, INTERNAL MEDICINE, 51(18) (18), 2613 - 2616, English[Refereed]Scientific journal
- Aug. 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 94(2) (2), 193 - 202, EnglishScientific journal
- Jan. 2011, BONE MARROW TRANSPLANTATION, 46(1) (1), 148 - 149, English[Refereed]Scientific journal
- Dec. 2010, LEUKEMIA RESEARCH, 34(12) (12), E339 - E341, EnglishScientific journal
- Dec. 2010, BLOOD, 116(25) (25), 5528 - 5535, EnglishScientific journal
- Nov. 2010, INTERNATIONAL JOURNAL OF HEMATOLOGY, 92(4) (4), 642 - 646, English[Refereed]Scientific journal
- Sep. 2010, CANCER GENETICS AND CYTOGENETICS, 201(2) (2), 122 - 127, EnglishScientific journal
- Jun. 2010, CANCER GENETICS AND CYTOGENETICS, 199(2) (2), 134 - 138, EnglishScientific journal
- May 2010, ANNALS OF ONCOLOGY, 21(5) (5), 1129 - 1130, English[Refereed]Scientific journal
- Apr. 2010, INTERNATIONAL JOURNAL OF HEMATOLOGY, 91(3) (3), 542 - 545, English[Refereed]Scientific journal
- 2010, INTERNAL MEDICINE, 49(11) (11), 1031 - 1035, EnglishScientific journal
- Jan. 2010, LEUKEMIA RESEARCH, 34(1) (1), E38 - E41, English[Refereed]Scientific journal
- Nov. 2009, TRANSPLANTATION PROCEEDINGS, 41(9) (9), 3873 - 3876, English[Refereed]Scientific journal
- Oct. 2009, CANCER GENETICS AND CYTOGENETICS, 194(1) (1), 38 - 43, English[Refereed]Scientific journal
- Jun. 2009, MOLECULAR CANCER RESEARCH, 7(6) (6), 880 - 889, English[Refereed]Scientific journal
- Mar. 2009, LEUKEMIA RESEARCH, 33(3) (3), 377 - 383, English[Refereed]Scientific journal
- [Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic stem cell transplantation].Sinusoidal obstruction syndrome (SOS) is one of the life-threatening complications caused by endothelial damage to the hepatic sinusoids after hematopoietic stem cell transplantation. However, a satisfactory treatment for SOS has not yet been established. Defibrotide has anti-thrombotic, anti-ischemic, anti-inflammatory, and thrombolytic properties without systemic anticoagulant effects. We treated eight post-transplant SOS patients with defibrotide. Three patients responded to the therapy and the initial response was observed within a week. In addition to the improvement of liver function, rapid recovery of response to diuretic drugs followed by the improvement of renal function was observed. All of the five patients with respiratory dysfunction died despite administration of defibrotide, suggesting that early treatment might lead to better outcomes. There were no severe adverse effects directly due to defibrotide administration. Defibrotide seems to be a promising treatment for SOS, and the initiation of a clinical study in Japan would be important.Jan. 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50(1) (1), 3 - 8, Japanese, Domestic magazineScientific journal
- Jan. 2009, 臨床血液, 50(1) (1), 3 - 8, Japanese造血幹細胞移植後の類洞閉塞症候群に対するデフィブロタイドの有効性の検討[Refereed]Scientific journal
- Dec. 2008, INTERNATIONAL JOURNAL OF HEMATOLOGY, 88(5) (5), 599 - 601, English[Refereed]Scientific journal
- Jul. 2008, INTERNATIONAL JOURNAL OF HEMATOLOGY, 88(1) (1), 104 - 110, English[Refereed]Scientific journal
- May 2008, CANCER GENETICS AND CYTOGENETICS, 183(1) (1), 77 - 81, English[Refereed]Scientific journal
- Feb. 2008, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 367(1) (1), 90 - 96, EnglishScientific journal
- Dec. 2007, ANNALS OF HEMATOLOGY, 86(12) (12), 855 - 863, EnglishScientific journal
- Nov. 2007, CANCER GENETICS AND CYTOGENETICS, 179(1) (1), 69 - 75, EnglishScientific journal
- Nov. 2007, CANCER GENETICS AND CYTOGENETICS, 179(1) (1), 85 - 87, EnglishScientific journal
- Oct. 2007, BRITISH JOURNAL OF HAEMATOLOGY, 139(1) (1), 161 - 163, EnglishScientific journal
- Jul. 2007, 臨床血液, 48(7) (7), 576 - 580, Japanese骨髄限局増殖を来したT細胞性顆粒リンパ球白血病[Refereed]Scientific journal
- Jul. 2007, CANCER GENETICS AND CYTOGENETICS, 176(1) (1), 61 - 66, EnglishScientific journal
- Jul. 2007, CANCER GENETICS AND CYTOGENETICS, 176(2) (2), 144 - 149, EnglishScientific journal
- May 2007, TRANSPLANTATION, 83(9) (9), 1281 - 1282, English[Refereed]Scientific journal
- Apr. 2007, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 355(4) (4), 970 - 975, English[Refereed]Scientific journal
- Jan. 2007, TRANSPLANTATION, 83(2) (2), 220 - 224, English[Refereed]Scientific journal
- Nov. 2006, BLOOD, 108(11) (11), 838A - 838A, English[Refereed]
- Sep. 2006, AMERICAN JOURNAL OF HEMATOLOGY, 81(9) (9), 713 - 716, EnglishScientific journal
- Jan. 2006, CELL, 124(2) (2), 407 - 421, EnglishScientific journal
- Apr. 2005, JOURNAL OF EXPERIMENTAL MEDICINE, 201(8) (8), 1183 - 1189, English[Refereed]Scientific journal
- Oct. 2004, BLOOD, 104(7) (7), 2020 - 2026, English[Refereed]Scientific journal
- Aug. 2004, BLOOD, 104(4) (4), 993 - 1001, English[Refereed]Scientific journal
- Sep. 2003, BLOOD, 102(6) (6), 2060 - 2067, EnglishPSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha 4 integrin[Refereed]Scientific journal
- Jun. 2003, IMMUNITY, 18(6) (6), 789 - 800, EnglishGalactocerebrosides are required postnatally for stromal-dependent bone marrow lymphopoiesis[Refereed]Scientific journal
- Dec. 2001, AMERICAN JOURNAL OF HEMATOLOGY, 68(4) (4), 280 - 283, EnglishMonitoring of CD59 expression in paroxysmal nocturnal hemoglobinuria treated with danazol[Refereed]Scientific journal
- Jul. 2001, ANNALS OF HEMATOLOGY, 80(7) (7), 387 - 392, EnglishVery late antigen-5 and leukocyte function-associated antigen-1 are critical for early stage hematopoietic progenitor cell homing[Refereed]Scientific journal
- Mar. 2001, CANCER GENETICS AND CYTOGENETICS, 125(2) (2), 161 - 162, EnglishChromosome analysis after ex vivo expansion of CD34(+) cells from human cord blood[Refereed]Scientific journal
- Feb. 2001, JOURNAL OF RHEUMATOLOGY, 28(2) (2), 288 - 291, EnglishTelomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases[Refereed]Scientific journal
- Dec. 2000, LIVER, 20(6) (6), 491 - 491, EnglishAcute thrombocytopenic purpura after ingestion of Sho-saiko-to for hepatitis[Refereed]Scientific journal
- Nov. 2000, EXPERIMENTAL HEMATOLOGY, 28(11) (11), 1232 - 1238, EnglishIkaros expression in human hematopoietic lineages[Refereed]Scientific journal
- Oct. 2000, INTERNATIONAL JOURNAL OF HEMATOLOGY, 72(3) (3), 362 - 370, EnglishAllogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: A single-center experience[Refereed]Scientific journal
- Aug. 2000, CANCER GENETICS AND CYTOGENETICS, 121(1) (1), 86 - 89, EnglishDeletion 7p in gastric MALT lymphoma[Refereed]Scientific journal
- 2000, AUTOIMMUNITY, 32(1) (1), 67 - 72, EnglishDisproportion of helper T cell subsets in peripheral blood of patients with primary Sjogren's syndrome[Refereed]Scientific journal
- Jan. 2000, INTERNAL MEDICINE, 39(1) (1), 73 - 76, EnglishSjogren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome[Refereed]Scientific journal
- Jan. 2000, Int J Hematol, 71(4) (4), 328 - 33, EnglishGranulocyte colony-stimulating factor and lineage-independent modulation of VLA-4 expression on circulating CD34+ cells[Refereed]Scientific journal
- Nov. 1999, JOURNAL OF RHEUMATOLOGY, 26(11) (11), 2493 - 2495, EnglishIn vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine[Refereed]Scientific journal
- Nov. 1999, INTERNAL MEDICINE, 38(11) (11), 892 - 895, EnglishDouble high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer[Refereed]Scientific journal
- Jun. 1999, Leukemia Research, 23(6) (6), 559 - 568, English[Refereed]Scientific journal
- Apr. 1999, BONE MARROW TRANSPLANTATION, 23(7) (7), 659 - 665, EnglishHematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period[Refereed]Scientific journal
- Jan. 1999, ANTICANCER RESEARCH, 19(1B) (1B), 693 - 698, EnglishHigh-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer[Refereed]Scientific journal
- Jan. 1999, INTERNATIONAL JOURNAL OF HEMATOLOGY, 69(1) (1), 36 - 42, EnglishAnalysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation[Refereed]Scientific journal
- Nov. 1998, ALLERGY, 53(11) (11), 1101 - 1103, EnglishImprovement with disodium cromoglycate of neutrophil phagocytosis and respiratory burst activity in a patient with hyperimmunoglobulin E syndrome[Refereed]Scientific journal
- Aug. 1998, INTERNATIONAL JOURNAL OF HEMATOLOGY, 68(2) (2), 157 - 168, EnglishReplating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin[Refereed]Scientific journal
- Jun. 1998, ANNALS OF HEMATOLOGY, 76(6) (6), 279 - 282, EnglishMyelodysplastic syndrome with translocation (8;21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?[Refereed]Scientific journal
- Mar. 1998, AMERICAN JOURNAL OF HEMATOLOGY, 57(3) (3), 238 - 240, EnglishBone marrow necrosis in a patient with acute myeloblastic leukemia during administration of G-CSF and rapid hematologic recovery after allotransplantation of peripheral blood stem cells[Refereed]Scientific journal
- Feb. 1998, INTERNATIONAL JOURNAL OF HEMATOLOGY, 67(2) (2), 199 - 203, EnglishTrisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia[Refereed]Scientific journal
- Sep. 1997, LEUKEMIA, 11(9) (9), 1469 - 1477, EnglishTwo acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)[Refereed]Scientific journal
- Aug. 1997, INTERNATIONAL JOURNAL OF HEMATOLOGY, 66(2) (2), 169 - 178, EnglishG-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF[Refereed]Scientific journal
- Aug. 1997, LEUKEMIA, 11(8) (8), 1380 - 1382, EnglishClonal evolution to acute myeloblastic leukemia with MLL gene rearrangement from trisomy 8 clone[Refereed]Scientific journal
- Jun. 1997, BRITISH JOURNAL OF HAEMATOLOGY, 97(3) (3), 626 - 634, EnglishCommon clonal origin of lymphocytes and plasma cells in splenic lymphoma with villous lymphocytes[Refereed]Scientific journal
- Feb. 1997, BONE MARROW TRANSPLANTATION, 19(3) (3), 283 - 287, EnglishThe effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells[Refereed]Scientific journal
- Dec. 1996, INTERNATIONAL JOURNAL OF HEMATOLOGY, 65(1) (1), 89 - 92, EnglishAndrogen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia[Refereed]Scientific journal
- Apr. 1996, LEUKEMIA, 10(4) (4), 609 - 614, EnglishLow-dose melphalan for treatment of high-risk myelodysplastic syndromes[Refereed]Scientific journal
- Feb. 1996, INTERNATIONAL JOURNAL OF HEMATOLOGY, 63(2) (2), 149 - 154, EnglishAutoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome)[Refereed]Scientific journal
- The bone marrow (BM) is located inside the bone. Now, it appears that bone tissue functionally communicates with the BM hematopoietic system. Osteoblast lineage cells serve as a part of the microenvironment for immature hematopoietic (stem/progenitor) cells. In contrast, mature hematopoietic cells such as neutrophils and macrophages play a critical role to regulate osteoblast activity. A progressive distortion of this precise inter-organ communication between hematopoietic and skeletal systems may lead to hematologic disorders. Recent studies have revealed that vitamin D receptor is a pivotal bridging molecule for this network and for the pathogenesis of myelofibrosis.Last, Mar. 2020, Journal of bone and mineral metabolism, 38(2) (2), 145 - 150, English, Domestic magazine[Refereed]
- The functions of vitamin D receptor (VDR) have been extensively studied, for example, in the bone biology field. It is widely known that VDR knockout mice display the characteristic features of rickets type II. However, the contribution of VDR signaling to bone marrow (BM) hematopoiesis in association with the phenomena observed in clinical hematology has not been evaluated thoroughly. Hematopoietic stem cells (HSCs) can be mobilized from the BM into and harvested from peripheral blood as a BM transplantation source for the curable treatment of hematologic malignancies. This HSC mobilization can be achieved by the administration of cytokine granulocyte colony-stimulating factor (G-CSF) for several consecutive days. We have reported that, using the murine model, G-CSF induces the high sympathetic tone in the BM and a β2-adrenergic signal into osteoblasts induces a rapid and drastic increase of VDR, which is critical for the subsequent cascade for HSC mobilization. This is an example of the transient deviation of the inter-organ communication in three different systems (nervous, skeletal, and hematopoietic) bridged by VDR in osteoblasts. It would be important to reconsider VDR as a pivotal molecule that mediates inter-organ communication to broaden the application of vitamin D signal modulators.Jun. 2019, The Journal of steroid biochemistry and molecular biology, 190, 281 - 283, English, International magazine[Refereed]
- Mar. 2019, Clinical Calcium, 29(3) (3), 75 - 79, JapaneseWntシグナルによる造血幹細胞運命制御[Invited]Introduction commerce magazine
- Dec. 2018, 日本内科学会雑誌, 107(12号) (12号), 2546 - 2554, Japanese「神戸大学的」Clinical Problem-Solving 1ヵ月続く発熱と腹痛で入院した17歳男性[Refereed]Others
- Nov. 2018, BLOOD, 132, EnglishSummary international conference
- Dec. 2017, Clinical Calcium, 27(12) (12), 77 - 84, Japanese自然免疫細胞によるOsteoimmunologyIntroduction commerce magazine
- Nov. 2017, 炎症と免疫, 25(6) (6), 7 - 14, Japanese骨髄造血微小環境と骨代謝Introduction commerce magazine
- Sep. 2017, 臨床免疫・アレルギー科, 68(3) (3), 303 - 309, Japanese腫瘍性好酸球増多Introduction commerce magazine
- Sep. 2017, 血液内科, 75(3) (3), 364 - 368, Japanese交感神経による好中球を介したG-CSFによる動員調整機構Introduction commerce magazine
- Aug. 2017, 血液内科, 75(2) (2), 151 - 156, Japanese好酸球増多の病態と鑑別診断Introduction commerce magazine
- Aug. 2017, Medical Technology, 45(8) (8), 787 - 788, JapaneseFIP1L1-PDGFRα融合遺伝子検査の新規保険適用Introduction commerce magazine
- Jun. 2017, Clinical Calcium, 27(6) (6), 7, Japanese特集 幹細胞システム(特集ゲスト編集) 巻頭言~幹細胞システム~生体の横糸と縦糸Introduction commerce magazine
- Apr. 2017, 日本臨床皮膚科医会雑誌, 34(2号) (2号), 294, Japanese高齢発症の骨髄性プロトポルフィリン症の1例Meeting report
- Jul. 2016, Clinical Calcium, 26(8) (8), 9 - 16, Japanese骨細胞とオステオネットワーク[Invited]Introduction commerce magazine
- Apr. 2016, Clinical Calcium, 26(5) (5), 55 - 60, Japanese骨芽細胞系列とリンパ球造血[Invited]Introduction commerce magazine
- Feb. 2016, 分子リウマチ治療, 9(1) (1), 31 - 35, Japanese骨細胞による造血・免疫・エネルギー代謝制御[Invited]Introduction commerce magazine
- 2016, 日本造血細胞移植学会総会プログラム・抄録集, 38thG-CSF投与時の副反応のメカニズム-交感神経支配下の好中球によるPGE2産生
- 金原出版, Nov. 2015, 整形・災害外科, 58(12) (12), 1605 - 1610, Japanese骨細胞による造血・免疫・エネルギー代謝制御[Invited]Introduction commerce magazine
- 最新医学社, Oct. 2015, 最新医学, 70(10) (10), 2035 - 2042, JapaneseInter-organ Communication Regulated by Osteocytes : Hematopoietic Stem Cells, Lymphopoiesis and Energy Metabolism
- Oct. 2015, 最新医学, 70(10) (10), 143 - 150, Japanese骨細胞による多臓器制御 ー造血幹細胞・免疫システムからエネルギー代謝までー[Invited]Introduction commerce magazine
- Sep. 2015, 細胞, 47(10) (10), 484 - 487, Japanese骨細胞による全身代謝調節機構[Invited]Introduction commerce magazine
- Aug. 2015, 診断と治療, 103(5) (5), 655 - 660, Japanese好酸球増多症候群(HES)の新分類と腫瘍性HESの分子標的治療[Invited]Introduction commerce magazine
- Aug. 2015, アレルギーの臨床, 35(474) (474), 17 - 21, Japanese好酸球増多症候群と腫瘍性疾患[Invited]Introduction commerce magazine
- Current Medicine Group LLC 1, Aug. 2015, Current osteoporosis reports, 13(4) (4), 193 - 7, English, International magazine[Refereed]
- Jul. 2015, 成人病と生活習慣病, 45(7) (7), 871 - 878, Japanese好酸球浸潤と血液疾患[Invited]Introduction commerce magazine
- ニューサイエンス社, May 2015, 細胞, 47(5) (5), 254 - 257, JapaneseRegulation of hematopoiesis by osteocytes : "seed and soil" based on inter-organ communication
- Mar. 2015, 血液フロンティア, 25(3) (3), 17 - 19, Japanese特集 骨髄学~造血ニッチ研究から見えてきた形態学から分子基盤まで~ 序 ~血球学から骨髄学へ~[Invited]Introduction commerce magazine
- The bone contains the bone marrow. The functional communication between bone cells and hematopoiesis has been extensively studied in the past decade or so. Osteolineage cells and their modulators, such as the sympathetic nervous system, macrophages and osteoclasts, form a complex unit to maintain the homeostasis of hematopoiesis, called the 'microenvironment'. Recently, bone-embedded osteocytes, the sensors of gravity and mechanical stress, have joined the microenvironment, and they are demonstrated to contribute to whole body homeostasis through the control of immunity and energy metabolism. The inter-organ communication orchestrated by the bone is summarized in this article.2015, BoneKEy reports, 4, 748 - 748, English, International magazine[Refereed]
- Dec. 2014, BLOOD, 124(21) (21), EnglishNeutrophils Modulate Osteoblastic Niche for Hematopoietic Progenitors Via Prostaglandin E2 Production Triggered By Sympathetic Nervous SystemSummary international conference
- Sep. 2014, 炎症と免疫, 22(5) (5), 16 - 21, Japanese骨細胞による造血制御[Invited]Introduction commerce magazine
- Jul. 2014, CLINICAL CALCIUM, 24(7) (7), 69 - 76, Japanese骨髄造血と骨・血管連関[Invited]Introduction commerce magazine
- Jun. 2014, INTERNATIONAL JOURNAL OF HEMATOLOGY, 99(6) (6), 679 - 684, EnglishIntroduction scientific journal
- Jun. 2014, INTERNATIONAL JOURNAL OF HEMATOLOGY, 99(6) (6), 677 - 678, EnglishOthers
- May 2014, 実験医学 増刊 骨代謝 つくり、壊し、変えるーそのメカニズムと最新治療, 32(7) (7), 64 - 69, Japanese造血環境と骨代謝[Invited]Introduction commerce magazine
- Apr. 2014, CLINICAL CALCIUM, 24(4) (4), 85 - 92, Japanese骨代謝による造血環境制御[Invited]Introduction commerce magazine
- 14 Feb. 2014, 日本造血細胞移植学会総会プログラム・抄録集, 36th, 226, Japanese同種臍帯血移植におけるCMV再活性化に対しHLA不一致が及ぼす影響
- 14 Feb. 2014, 日本造血細胞移植学会総会プログラム・抄録集, 36th, 238, JapaneseHLA一致血縁または7‐8/8HLA一致非血縁ドナーからの同種造血細胞移植におけるMMFおよびカルシニューリン阻害剤を用いたGVHD予防の有用性:多施設共同第2相臨床試験
- 2014, 腎と骨代謝, 27(2) (2), 157 - 163, Japanese骨と血液 ー造血幹細胞と骨芽細胞ニッチについてー[Invited]Introduction commerce magazine
- 2014, Inflammation and Cell Signaling, e244, EnglishIntroduction scientific journal
- Nov. 2013, BLOOD, 122(21) (21), EnglishSummary international conference
- Feb. 2013, JOURNAL OF BONE AND MINERAL RESEARCH, 28, EnglishProstaglandin E2 Regulates Osteoblastic Niche Selectively for Hematopoietic Progenitors through Induction of Osteopontin via EP4 ReceptorSummary international conference
- 2013, THE BONE, 27, 71 - 75, Japanese骨細胞による多臓器制御[Invited]Introduction commerce magazine
- 2013, G-CSF(顆粒球コロニー刺激因子)の基礎と臨床(東條有伸 編), 42 - 52, JapaneseG-CSFによる造血幹細胞動員のメカニズム[Invited]Introduction commerce magazine
- Oct. 2012, 臨床血液, 53(10) (10), 1819 - 1825, Japanese造血幹細胞ニッチ[Invited]Introduction scientific journal
- Sep. 2012, 医学のあゆみ, 242(9) (9), 712 - 716, Japanese骨芽細胞ニッチと造血幹細胞のコントロール[Invited]Introduction scientific journal
- 「臨床血液」編集部, Aug. 2012, 臨床血液, 53(8) (8), 785 - 787, JapaneseCD5, CD7 の両方またはいずれかの発現低下が診断の契機となった単クローン性Tリンパ球増加症[Refereed]Report scientific journal
- Jul. 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 96(1) (1), 10 - 25, English[Refereed]Book review
- Jan. 2012, Annual Review 血液, 2012, 9 - 15, Japanese造血幹細胞 造血幹細胞動員の分子メカニズムIntroduction scientific journal
- Nov. 2011, BLOOD, 118(21) (21), 327 - 328, EnglishSummary international conference
- Sep. 2011, 血液内科, 63(3) (3), 326 - 331, Japanese造血幹細胞動員の基礎と臨床:最近の話題Introduction scientific journal
- Jul. 2011, 臨床血液, 52(7) (7), 447 - 451, JapaneseMDSに対するレナリドマイド治療の分子作用機序Introduction scientific journal
- Apr. 2011, BONE MARROW TRANSPLANTATION, 46, S97 - S98, EnglishPharmacokinetics-based optimal dose prediction of mycophenolate mofetil in unrelated haematopoietic cell transplantation: proposal of strategies depending on donor sourceSummary international conference
- 科学評論社, Apr. 2011, 血液内科, 62(4) (4), 513 - 517, Japanese5q-症候群に関する最近の話題Introduction scientific journal
- Mar. 2011, 血液フロンティア, 21(3) (3), 96 - 99, Japanese造血幹細胞制御における3B(Brain-Bone-Blood)ネットワークIntroduction scientific journal
- 科学評論社, Mar. 2011, 血液内科, 62(3) (3), 376 - 381, Japanese造血幹細胞ニッチの神経調節におけるビタミンD受容体の意義Introduction scientific journal
- Nov. 2010, ANNALS OF ONCOLOGY, 21, 37 - 38, EnglishA NEW ALTERNATIVE STRATEGY FOR STAGE I IMATINIB-SENSITIVE TESTICULAR SEMINOMA; LESSONS FROM A CASE WITH PH plus ALLSummary international conference
- Nov. 2010, BLOOD, 116(21) (21), 126 - 126, EnglishA Novel Feedback Mechanism by Ephrin-B1/B2 In T Cell Activation: Concentration-Dependent Switch From Costimulation to InhibitionSummary international conference
- 2010, 日本造血細胞移植学会総会プログラム・抄録集, 32nd, 230, Japanese急性GVHD予防薬ミコフェノール酸モフェチル(MMF)至適投与法の確立に関する研究(第4報)
- 2010, 日本臨床腫瘍学会学術集会プログラム・抄録集, 8th, 273, Japaneseフィラデルフイア染色体陽性急性リンパ性白血病合併例から学ぶ,限局期精巣セミノーマに対するイマチニブを用いた新たな治療戦略
- Apr. 2009, 実験医学, 27(6) (6), 871 - 875, Japanese【骨免疫制御のメカニズム 免疫応答の理解から関節リウマチをはじめとした骨関連疾患の治療まで】 造血幹細胞ニッチと骨代謝Introduction scientific journal
- Nov. 2008, BLOOD, 112(11) (11), 769 - 770, EnglishThe Promising Strategy of Mycophenolate Mofetil Dosing to Prevent Moderate- to Severe-Acute Graft-Versus-Host Disease.Summary international conference
- 2008, 臨床血液, 49(9) (9)原発性硬化胆肝炎(PSC)経過中に発症し,生体肝移植後に貧血の改善を示した赤芽球癆(PRCA)の一例
- 2008, 今日の移植, 21(1) (1), 59 - 65, Japanese接着分子と造血幹細胞の生着と動員 (マクロファージフォーラム Mini-review)Introduction scientific journal
- 科学評論社, Jun. 2007, 血液・腫瘍科, 54(6) (6), 655 - 661, Japanese(特集:造血幹細胞とその異常) 造血幹細胞動員のメカニズムIntroduction scientific journal
- 2007, 臨床血液, 48(9) (9)類洞閉塞症候群(SOS)発症予測因子としての血小板凝集能検査の有用性
- 秀潤社, 2007, 細胞工学, 26(5) (5), 493 - 496, Japanese造血幹細胞ニッチの神経系による調節(特集 幹細胞新世紀:ES細胞・体性幹細胞の新たなポテンシャル)Introduction scientific journal
- 2007, 分子細胞治療, 6(4) (4), 90 - 91, Japanese(用語解説)CD44Introduction scientific journal
- Jan. 2007, Annual Review 2007 血液, 2007, 38 - 45, Japanese造血系細胞のニッチからの遊離における交感神経系の役割Introduction scientific journal
- (一社)日本血液学会-東京事務局, Sep. 2006, 臨床血液, 47(9) (9), 1134 - 1134, Japanese再発・治療抵抗性非ホジキンリンパ腫に対するIDEA療法の有効性と安全性の検討
- Aug. 2006, 分子細胞治療, 5(4) (4), 76 - 77, Japanese交感神経系シグナルによる骨髄から末梢血への造血幹細胞動員の制御Introduction scientific journal
- May 2006, 実験医学, 24(7) (7), 952 - 955, Japanese交感神経系シグナルによる骨髄ニッチからの造血幹細胞遊走の制御Introduction scientific journal
- 1994, 先端医療, 5, 49 - 52, Japanese幹細胞増幅と造血因子Introduction scientific journal
- Contributor, 好酸球増多症候群•慢性好酸球性白血病, 中外医学社, Oct. 2019, 124-133, Japanese, ISBN: 9784498225183未来型血液治療学Scholarly book
- Others, 朝倉書店, Mar. 2017, Japanese内科学 第11版 / 表面マーカーScholarly book
- Others, 診断と治療社, May 2016, Japanese血液科 研修ノート / 第2章 血液の機能と仕組み 1. 造血システムTextbook
- Others, メディカルレビュー社, Feb. 2016, Japanese骨・臓器ネットワークとオステオサイト / 骨細胞による遠隔臓器の制御Scholarly book
- Others, 中外医学社, Jan. 2015, JapaneseAnnual Review 2015 血液 / 骨細胞による造血細胞制御:多臓器間ネットワークに支えられる造血システムScholarly book
- Others, 医薬ジャーナル社, Jul. 2013, JapaneseG-CSF(顆粒球コロニー刺激因子)の基礎と臨床 / G-CSFによる造血幹細胞動員のメカニズムScholarly book
- Others, 中外医学社, Jan. 2012, JapaneseAnnual Review 2012 血液 / 造血幹細胞動員の分子メカニズムScholarly book
- Others, 中外医学社, Jan. 2007, JapaneseAnnual Review 2007 血液 / 造血系細胞のニッチからの遊離における交感神経の役割Scholarly book
- Others, 南江堂, May 2001, Japanese末梢血幹細胞移植の実際 [5. 末梢血幹細胞の凍結保存]Scholarly book
- 第81回日本血液学会学術集会, Oct. 2019, EnglishCritical regulation of mobilization efficiency by fat via marrow PPARδ(delta)Oral presentation
- 第80回 日本血液学会学術集会, Oct. 2018, Japanese, 大阪, Domestic conferenceErythroblasts facilitate progenitor mobilization via FGF23 production under neuronal controlOral presentation
- 第19回日本検査血液学会学術集会, Jul. 2018, Japanese, 大宮, Domestic conference慢性好塩基球性白血病から急性骨髄性白血病へと進展した一症例Oral presentation
- 第36回 日本骨代謝学会学術集会, Jul. 2018, Japanese, 長崎, Domestic conference神経・炎症・造血のクロストーク[Invited]Nominated symposium
- 4th Congress on Steroid Research 2018, Jul. 2018, English, ソウル, International conferenceVitamin D receptor: a bridging molecule for inter-organ commumication between skeletal and hematopoietic systems[Invited]Nominated symposium
- 第27回日本サイトメトリー学会学術集会, Jun. 2017, Japanese, 一般社団法人 日本サイトメトリー学会, 神戸, Domestic conference骨・骨髄機能連関のひずみとしての造血器疾患[Invited]Nominated symposium
- The 2nd Congress of joint European Neonatal Society, May 2017, English, MCA Scientific Events, Venice, Italy, International conferenceA new evaluation index for left-right unequal ventriculomegaly in very low birth weight infants: Association with walking disabilities at 1.6 years of corrected agePoster presentation
- The 39th Annual Meeting of the Japan Socitey for Hematopoietic Cell Transplantation, Mar. 2017, Japanese, The Japan Society for Hematopoietic Cell Transplantation, 島根, Domestic conferenceDefibrotide and Thrombomodulin Treatment for Late Onset Sinusoidal Obstruction Syndrome after allo-HSCTOral presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conferenceEarly Initiation of Defibrotide or Thrombomodulin Treatment for Sinusoidal Obstruction SyndromeOral presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conference広範な皮下血腫と高度の貧血を呈した真性多血症と第XIII/13因子(F13)欠乏症の合併症例Poster presentation
- 第67回日本皮膚科学会中部支部学術大会, Oct. 2016, Japanese, 日本皮膚科学会中部支部, 大阪, Domestic conferenceトシリズマブによる長期間の治療効果を観察し得た多中心性キャッスルマン病に伴う皮膚形質細胞症の1例Oral presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conferenceG-CSF primes bone marrow neutrophils to produce prostaglandin E2 via sympathetic nervous systemOral presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conferenceEarly initiation of defibrotide or thrombomodulin treatment for sinusoidal obstruction syndromeOral presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conferenceCharacteristic symptoms of systemic auto-inflammatory disease (SAID) in a patient with MDSPoster presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conferenceA prospective study of very low-dose lenalidomide (miniRd) in elderly relapsed/refractory myelomaOral presentation
- 第38回日本光医学・光生物学会, Jul. 2016, Japanese, 日本光医学・光生物学会, 京都, Domestic conference骨髄異形性症候群に合併した高齢発症骨髄性プロトポルフィルン症の1例Oral presentation
- 42nd, Annual Meeting of the European Society for Blood and Marrow Transplantation, Apr. 2016, English, European Society for Blood and Marrow Transplantation, Valencia, Spain, International conferenceNationwide Survey of Defbrotide and Recombinant Human Soluble Thrombomodulin for Treatment of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell TransplantationOral presentation
- Pediatric Academic Societies (PAS) Annual Meeting 2016, Apr. 2016, English, Pediatric Academic Societies, Baltimore, USA, International conferenceIncidence of kernicterus in Japanese preterm infants <30 wks gestation born in 2011Poster presentation
- 第38回日本造血細胞移植学会総会, Mar. 2016, Japanese, 日本造血細胞移植学会, 名古屋, Domestic conferenceThe mechanism of fever and bone pain by G-CSF administration-production of PGE2 from neutrophils governed by synpathetic neuvous systemOral presentation
- 第77回日本血液学会, Oct. 2015, English, 日本血液学会, 金沢, Domestic conferenceαSMA+ macrophages skewed from HSCs by vitamin D3 initiate myelofibrosis with osteosclerosisOral presentation
- 第77回日本血液学会, Oct. 2015, Japanese, 日本血液学会, 金沢, Domestic conferenceA successful treatment with low-dose rituximab for AIHA severe steroid-psychosisOral presentation
- 第77回日本血液学会, Oct. 2015, Japanese, 日本血液学会, 金沢, Domestic conferenceA retrospective study evaluating clinical bleeding score and factor XIII in acquired hemorrhageOral presentation
- 44th Annual Scientific Meeting of the ISEH, Sep. 2015, English, International Society for Experimental Hematology, 京都, Domestic conferenceLympho-hematopoetic Microvironment Regulated by Inter-oran Communication[Invited]Invited oral presentation
- 日本骨代謝学会学術集会, Jul. 2015, Japanese, 日本骨代謝学会, 東京, Domestic conference骨を中心とした他臓器関連:その一時的歪みの臨床応用と破綻による造血器疾患[Invited]Invited oral presentation
- 48th Annual Meeting of the Japanese Society of Developmental Biologists Symposium 6:Cell-cell interaction in tissue stem cell regulation, Jun. 2015, English, 日本発生生物学会, 茨城, Domestic conferenceLympho-hematopoetic microvironment regulated by inter-oran communication[Invited]Invited oral presentation
- The 37th Annual Meeting of the Japan Society for Hematopoietic, Mar. 2015, Japanese, 日本造血細胞移植学会, 神戸, Domestic conferenceMobilization of Hematooietic Stem Cells[Invited]Invited oral presentation
- The 37th Annual Meeting of the Japan Society for Hematopoietic, Mar. 2015, Japanese, 日本造血細胞移植学会, 神戸, Domestic conferenceMicroenvironment-intrinsic leukemia:oerviewOral presentation
- 日本免疫学会総会, Dec. 2014, English, 日本免疫学会, 京都, Domestic conferenceRegulation of lympho-hematopoetic microenvironment by inter-organ communication[Invited]Invited oral presentation
- 56th American Society Hematolory of Annual Meeting and Exposition, Dec. 2014, English, American Society of Hematology, San Francisco, USA, International conferenceHematopoiesis and Stem Cells:Microenvironment,Cell Adhesion and Stromal Stem Cells:Civersity of the Hematopoietic Stem Cell NicheOral presentation
- Recent Advances in Immunology and Inflammation 2014, Nov. 2014, English, 九州大学 生体防御医学研究所, 福岡, Domestic conferenceLympho-hematopoetic microenvironment regulated by inter-organ communication[Invited]Invited oral presentation
- 第35回日本肥満学会, Oct. 2014, Japanese, 日本肥満学会, 宮崎, Domestic conference骨を頂点とした他臓器関連に支えられる免疫・代謝システム[Invited]Invited oral presentation
- The 76th Annual Meeting of the Japanese Society of Hematology, Oct. 2014, Japanese, 日本血液学会, 大阪, Domestic conferenceRecurrence of large-vessel vasculitis and development of Sweet syndrome after 5-azacytidinePoster presentation
- The 76th Annual Meeting of the Japanese Society of Hematology, Oct. 2014, Japanese, 日本血液学会, 大阪, Domestic conferenceAn Extremely indolent EBV-positive diffuse large B-cell lymphoma of the elderlyPoster presentation
- The 76th Annual Meeting of the Japanese Society of Hematology, Oct. 2014, Japanese, 日本血液学会, 大阪, Domestic conferenceA case of B-cell prolymphocytic leukemia that was successfully treated with ituximabPoster presentation
- 第19回アディポサイエンス・シンポジウム, Aug. 2014, Japanese, 日本肥満学会, 大阪, Domestic conference骨細胞と脂肪組織:骨を頂点とした多臓器連関[Invited]Invited oral presentation
- 第32回日本骨代謝学会学術集会, Jul. 2014, Japanese, 日本骨代謝学会, 大阪, Domestic conference骨・骨髄による多臓器制御[Invited]Invited oral presentation
- 第35回日本炎症・再生医学会(第1回骨免疫会議), Jul. 2014, Japanese, 日本免疫炎症・再生医学会(日本骨免疫会議), 沖縄, Domestic conference骨による免疫系細胞の制御機構[Invited]Invited oral presentation
- 第101回近畿血液学地方回, Jun. 2014, Japanese, 近畿血液学地方会, 大阪, Domestic conference多臓器関連に支えられる造血システム[Invited]Invited oral presentation
- 第87回日本内分泌学会学術総会, Apr. 2014, Japanese, 日本内分泌学会, 福岡, Domestic conference骨による免疫と脂肪代謝の制御[Invited]Invited oral presentation
- 第14回抗加齢医学学会総会, Apr. 2014, Japanese, 日本抗加齢医学会, 大阪, Domestic conference交感神経シグナルによる骨髄造血幹細胞の運命制御[Invited]Invited oral presentation
- The 36th Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation, Mar. 2014, Japanese, 日本造血細胞移植学会, 沖縄, Japan, Domestic conferenceLate-onset reversible cardiomypathy without significant lymphocytic infiltration in patients with chronic graft-versus-host disease(GVHD)Poster presentation
- 55th ASH Annual Meeting and Exposition, Dec. 2013, English, American Society of Hematology, New Orleans, USA, International conferenceαSMA+Macrophages Skewed From Hematopoietic Stem Cells By Vitamin D3 Intiate Myelofibrosis and Subsequent OsteosclerosisOral presentation
- 55th ASH Annual Meeting and Exposition, Dec. 2013, English, American Society of Hematology, New Orleans, USA, International conferenceGvhd Prophylaxis With Mycophenolate Mofetil and Clacineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matche SibligsOr 7-8/8HLA-Matched Unrelated Volunteer Donors;A Japanese,Multicenter,Phase II TrialOral presentation
- The Japanese Society of Hematology, Oct. 2013, Japanese, 日本血液学会, 札幌, Japan, Domestic conferenceTripile-hit lymphoma with t(3;8) (q27;q24)BCL6/MYC fusion genePoster presentation
- The Japanese Society of Hematology, Oct. 2013, Japanese, 日本血液学会, 札幌, Japan, Domestic conferenceRole of matrix-embedded osteocytes in hematopoietic stem/progenitor cell niche regulationOral presentation
- ASBMR 2013 Annual Meeting, Oct. 2013, English, American Society for Bone and Mineral Research, Baltimore, USA, International conferenceProstaglandin E2 Regulates Osteoblastic Niche Selectively for Hematopoietic Progenitors through Induction of Osteopontin via EP4 ReceptorPoster presentation
- The Japanese Society of Hematology, Oct. 2013, Japanese, 日本血液学会, 札幌, Japan, Domestic conferenceProstaglandin E2 Regulates Osteoblastic Niche by the induction of osteopontin via EP4 receptorOral presentation
- The Japanese Society of Hematology, Oct. 2013, Japanese, 日本血液学会, 札幌, Japan, Domestic conferenceHIV-negative,HHV-8-unrelated primary effusion lymphoma-like lymphoma with genotypic infidelityPoster presentation
- 第34回日本炎症・再生医学会, Jul. 2013, Japanese, 日本炎症・再生医学会, 京都, Japan, Domestic conference骨を要とする多臓器間ネットワークとそれに支えられる造血システム[Invited]Nominated symposium
- The 35th Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation, Mar. 2013, Japanese, The Japan Society for Hematopoietic Cell Transplantation, 金沢, Domestic conferenceステロイド治療が著効したリンパ球浸潤を伴わない心GVHDPoster presentation
- The 74th Annual Meeting of the Japanese Society of Hematology, Oct. 2012, Japanese, The Japanese Society of Hematology, 京都, Domestic conferenceVery low dose lenalidomide with dexamethasone for elderly patients with multiple myelomaPoster presentation
- The 74th Annual Meeting of the Japanese Society of Hematology, Oct. 2012, Japanese, The Japanese Society of Hematology, 京都, Domestic conferenceSuccessful management of obstructive jaundice by gallstone in a case of PNH with EculizumabPoster presentation
- 2012 Annual Meeting of The American Society for Bone and Mineral Research, Oct. 2012, English, The American Society for Bone and Mineral Research, Minneapolis, USA, International conferenceOsteocytes in the Homeostasis of Remote OrgansOral presentation
- The 74th Annual Meeting of the Japanese Society of Hematology, Oct. 2012, Japanese, The Japanese Society of Hematology, 京都, Domestic conferenceInhibitor-negative severe acquired factor XIII/13 deficiency with aggressive subdural hemorrhagePoster presentation
- The 74th Annual Meeting of the Japanese Society of Hematology, Oct. 2012, Japanese, The Japanese Society of Hematology, 京都, Domestic conferenceAssociation of chronic interstitial pneumonia with chronic neutrophilic leukemiaPoster presentation
- The 74th Annual Meeting of the Japanese Society of Hematology, Oct. 2012, Japanese, The Japanese Society of Hematology, 京都, Domestic conferenceA novel zinc finger protein TFL suppresses IL-17-dependent T-cell-mediated autoimmune disease.Oral presentation
- The 30th Annual Meeting of the Japanese Society for Bone and Mineral Research, Jul. 2012, Japanese, The Japanese Society for Bone and Mineral Research, 東京, Domestic conference骨細胞による遠隔臓器機能の制御 "骨を起点とした新たな臓器間ネットワーク"Oral presentation
- 第35回日本造血細胞移植学会, Mar. 2012, Japanese, 日本造血細胞移植学会, 金沢, 第二寛解期(CR2)以降でのALLの移植成績は第一寛解期(CR1)に比べ劣る報告がなされ、ALL CR1の同種移植の重要性は高まっている。しかし、代替ドナーでは非血縁骨髄バンクドナーの移植(UR-BMT)が第一選択で臍帯血移植(CBT)はGVLの弱さから骨髄バンクドナーが得られない状況下でのみ使用されることが多い。一方、移植成績については慢性GvHDなどの移植後晩期TRMを考慮すると、短期間の観察ではその良悪を論ずることは難しい。我々の施設におけるALLの移植データを後方視的に解析し、CBTとUR-BMTの長期移植成績の比較を行った。(結果)2005年から2009年のALLの同種移植施行患者の総数は32名(移植時年齢 17~68, 中央値47.5歳)であり、そのうちCR1での移植の5年生存率は57.8% (N=21, 観察期間 40日~2,706日、, Domestic conference第一寛解期ALLに対する臍帯血移植の意義 ~単施設長期フォローアップデータ~Poster presentation
- 第34回日本造血細胞移植学会, Feb. 2012, Japanese, 日本造血細胞移植学会, 大阪, Domestic conferenceThe mechanusm of PBSC mobilizationInvited oral presentation
- 第53回米国血液学会, Dec. 2011, English, 米国血液学会, サンディエゴ, アメリカ, International conferenceOsteocytes Embedded Inside Bone Are Essential for G-CSF-InducedHematopoietic Stem/Progenitor MobilizationOral presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceRituximab prior to local radiotherapy prevents from relapse in ocular adnexal MALT lymphomaOral presentation
- 第73回日本血液学会学術集会, Oct. 2011, English, 日本血液学会, 愛知, Domestic conferenceRegulation of hematopoietic microenvironment by diverse organs-Everything has begun with a simpre bedside qustion-Invited oral presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceHistiocytic sarcoma with two immunohistopathologically distinct populationsPoster presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceDifferential phosphoproteome profiling in FIP1L1-PDGFRA negative hypereosinophilic syndromeOral presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceCritical regulation of stromal-dependent lymphopoiesis by bone-buried osteocytesOral presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceA novel feedback mechanism by ephrin-B1/B2 in T cell activationOral presentation
- 第73回日本血液学会学術集会, Oct. 2011, Japanese, 日本血液学会, 愛知, Domestic conferenceA novel activated lymphocyte marker TFL is highly expressed in follicular lymphoma but less in DLBCLOral presentation
- 第37回ヨーロッパ骨髄移植学会, Apr. 2011, English, ヨーロッパ骨髄移植学会, パリ, フランス, International conferencePharmacokinetics-based optimal dose prediction of mycophenolate moretil in unrelated hematopoietic cell transplantation:proposal of strategies depending on donor sourcePoster presentation
- 第33回日本造血細胞移植学会, Mar. 2011, Japanese, 日本造血細胞移植学会, 愛媛, Domestic conferenceEstablishment of PK-based MMF dosing in hematopoietic cell transplantation:Correlation of mycophenolic acid exposure to clinical outcomeOthers
- 52nd ASH ANNUAL MEETING AND EXPOSITION, Dec. 2010, English, The American Society of Hematology, オーランド, アメリカ, International conferenceA Nvel Feedback Mechanism by Ephrin-B1/B2 In T Cell Activation:Concentration-Dependent Switch From Cosimulation toInhibtionOral presentation
- 第72回日本血液学会学術集会, Sep. 2010, Japanese, 日本血液学会, 神奈川, Domestic conferenceExpressiom Pttern of a novel activated lymphocyte gene TFL at6q25 in malignant lymphomaOral presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceVITAMIN D receptor is essential for neuronal control of hematopoietic stem cell nicheOral presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceFatal H1N1 influenza infection in allogeneic stem cell transplantationPoster presentation
- The European Hematology Association, Jun. 2010, English, The European Hematology Association, バルセロナ, スペイン, International conferenceVITAMIN D RECEPTOR IS ESSENTIAL FOR NEURONAL CONTROL OF HEMATOPOIETIC STEM CELL NICHEOral presentation
- 第8回日本臨床腫瘍学会学術集会, Mar. 2010, Japanese, 日本臨床腫瘍学会, 東京, Domestic conferenceA new alternative strategy for stage I imatinib-sensitive testicular seminoma; lessons from a case associated with Philadelphia-positive acute lymphoblastic leukemiaPoster presentation
- 第32回日本造血細胞移植学会, Feb. 2010, Japanese, 日本造血細胞移植学会, 浜松, Domestic conference急性GVHD予防薬ミコフェノール酸モフェチル(MMF)至適投与法の確立に関する研究(第4報)Oral presentation
- 第92回近畿血液学地方会, Dec. 2009, Japanese, 近畿血液地方学会, 京都, Domestic conferenceImatinibが奏効したKIT+精巣原発セミノーマを合併したPh+ALLOral presentation
- 第71回日本血液学会学術集会, Oct. 2009, Japanese, 日本血液学会, 京都, Domestic conferenceAML carrying duplication of isodicentric chromosome 21,idic(21)(q11.2),leading to pentasomy21qPoster presentation
- 第71回日本血液学会学術集会, Oct. 2009, Japanese, 日本血液学会, 京都, Domestic conferenceTherapy-related,mixed phenotype acute leukemia with t(1;21)(q36;q22)and RUNX1 rearrangementPoster presentation
- 第71回日本血液学会総会, Oct. 2009, Japanese, 日本血液学会, 京都, Domestic conferenceA novel zinc finger protein, p58TFL at P-bodies inhibits human leukemia/lymphoma cell growthPoster presentation
- 第27回日本骨代謝学会学術総会, Jul. 2009, Japanese, 日本骨代謝学会, 大阪, Domestic conferenceResearch on bone, impact on hematologyInvited oral presentation
- 第7回日本臨床腫瘍学会学術集会, Mar. 2009, Japanese, 日本臨床腫瘍学会, 名古屋, Domestic conferenceハイリスク郡中高悪性度非ホジキンリンパ腫の第1寛解期におけるup-front自家末梢血幹細胞移植併用大量化学療法の意義Poster presentation
- 第7回日本臨床腫瘍学会学術集会, Mar. 2009, Japanese, 日本臨床腫瘍学会, 名古屋, Domestic conferenceハイリスク群中高悪性度非ホジキンリンパ腫の第1寛解期におけるup-front自家末梢血幹細胞移植併用大量化学療法の意義Poster presentation
- 第31回日本造血細胞移植学会総会, Feb. 2009, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference造血幹細胞移植後の類洞閉塞症候群に対するデフィブロタイドの有効性の検討Oral presentation
- 第31回日本造血細胞移植学会総会, Feb. 2009, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference急性GVHD予防薬としてのミコフェノール酸モフェチル(MMF)至適投与法の確立に関する研究Oral presentation
- 第50回米国血液学会年次総会, Dec. 2008, English, 米国血液学会, サンフランシスコ, 米国, International conferenceThe Promising Strategy of Mycophenolate Mofetil Dosing to Prevent Moderate- to Severe-Acute Graft-Versus-Host DiseasePoster presentation
- 第90回近畿血液学地方会, Nov. 2008, Japanese, 日本血液学会, 神戸, Domestic conferenceHodgkinリンパ腫関連血球貪食症候群を併発した骨髄異形成症候群Oral presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceSequential measurement of portal flow is helpful for assessment of SOS treatment with defibrotidePoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceUnbalanced translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in MDSPoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceEffectiveness of cord blood transplant for adult acute lymphoblastic leukemia in CRPoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferencePure red cell aplasia with primary screlosing cholangitis improved after liver transplantationPoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceThe promising strategy of MMF administration with 3-times daily after allogeneic transplantationPoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceFISH of a possible tumor suppressor gene of malignant lymphoma at 6q25Oral presentation
- 第29回 日本炎症・再生医学会, Jul. 2008, Japanese, 日本炎症・再生医学会, 東京, Domestic conferenceS9 骨免疫と再生 「造血幹細胞ニッチ制御と骨代謝」[Invited]Invited oral presentation
- 第6回 幹細胞シンポジウム, May 2008, Japanese, 幹細胞シンポジウム, 東京, Domestic conferenceRac 活性化分子Dock2の造血幹・前駆細胞における役割Poster presentation
- 第7回 血液フォーラム21, Mar. 2007, Japanese, 血液フォーラム21, 東京, Domestic conference造血幹細胞のゆりかごを揺らす手[Invited]Invited oral presentation
- 第3回 Practical Hematology, Feb. 2007, Japanese, Practical Hematology, 京都, Domestic conferenceHLA一致血縁者間同種末梢血幹細胞移植後早期に血小板輸血不応、体重増加、高ビリルビン血症を来たした急性リンパ性白血病の一例Oral presentation
- 第29回日本造血細胞移植学会総会, Feb. 2007, Japanese, 日本造血細胞移植学会, 福岡, Domestic conference術前の局所放射線照射領域に放射線肺臓炎を合併した同種骨髄移植症例の一例Poster presentation
- 第29回日本造血細胞移植学会総会, Feb. 2007, Japanese, 日本造血細胞移植学会, 福岡, Domestic conferenceドナー高齢化に伴う異性間移植キメリズム解析の問題点Poster presentation
- 第29回日本造血細胞移植学会総会, Feb. 2007, Japanese, 日本造血細胞移植学会, 福岡, Domestic conferencePharmacodynamicsに基づく急性GVHD/生着促進を目的としたミコフェノール酸モフェチル(MMF)投与法の確立に関する研究Poster presentation
- 日本分子生物学会2006フォーラム シンポジウム, Dec. 2006, Japanese, 日本分子生物学会, 名古屋, Domestic conference親はかわいい我が子に旅をさせる 造血細胞の骨髄から末梢血への動員メカニズム[Invited]Invited oral presentation
- 21世紀COEセミナー, Nov. 2006, Japanese, 大阪大学病理学, 大阪, Domestic conference旅する造血幹細胞とその水先案内人−造血幹細胞の骨髄からの出入りのメカニズム−[Invited]Invited oral presentation
- 第5回 血液腫瘍学術講演会, Nov. 2006, Japanese, 血液腫瘍学術講演会(浜松), 静岡, Domestic conference旅する造血幹細胞とその水先案内人[Invited]Invited oral presentation
- 第13回 福岡血液研究会, Nov. 2006, Japanese, 福岡血液研究会, 福岡, Domestic conference旅する造血幹細胞とその水先案内人[Invited]Invited oral presentation
- 第86回近畿血液学地方会, Nov. 2006, Japanese, 近畿血液学地方会, 和歌山, Domestic conference生着不全症例の臍帯血ミニ移植による救済法Oral presentation
- 第68回 日本血液学会・第48回 日本臨床血液学会合同総会, Oct. 2006, Japanese, 日本血液学会・日本臨床血液学会, 福岡, Domestic conference好中球CD44はE-セレクチンのリガンドであるOral presentation
- 第68回 日本血液学会・第48回 日本臨床血液学会合同総会, Oct. 2006, Japanese, 日本血液学会・日本臨床血液学会, 福岡, Domestic conferencet(7;9)(q22;q34)転座は急性骨髄性白血病における新たな再発性の染色体異常であるPoster presentation
- 学術講演会, Jul. 2006, Japanese, 京都大学小児科, 京都, Domestic conference旅する造血幹細胞とその水先案内人[Invited]Invited oral presentation
- 第24回日本骨代謝学会学術集会, Jul. 2006, Japanese, 日本骨代謝学会, 東京, Domestic conference造血幹細胞と骨インターフェースのゲノム学[Invited]Invited oral presentation
- 第1回合同班会議プログラム, Jun. 2006, Japanese, JALSG班会議, 名古屋, Domestic conference造血幹細胞が寄り道するお店は白血病細胞にも魅力的?[Invited]Invited oral presentation
- 第1回 先端医療フォーラム, May 2006, Japanese, 先端医療フォーラム, 岡山, Domestic conference旅する造血幹細胞とその水先案内人[Invited]Invited oral presentation
- 第4回先端血液学セミナー, May 2006, Japanese, 先端血液学セミナー, 東京, Domestic conference親はかわいい我が子に旅をさせる−造血幹細胞の骨髄から末梢血への動員メカニズム−[Invited]Invited oral presentation
- 第28回日本造血細胞移植学会総会, Feb. 2006, Japanese, 日本造血細胞移植学会, 東京, Domestic conferenceケモカイン Fractalkine/CX3CL1 および受容体CX3CR1陽性単球の慢性GVHDの病態への関与Oral presentation
- 第47回米国血液学会, Dec. 2005, English, 米国血液学会, アトランタ, International conferenceSulfated colominic acid enhances CXCR4 function and promotes hematopoietic stem/progenitor egress from bone marrowPoster presentation
- 第47回米国血液学会, Dec. 2005, English, 米国血液学会, アトランタ, International conferencePotential Involvement of chemokine fractalkine/CX3CL1 and CX3CR1high monocytes in chronic graft versus host diseasePoster presentation
- 第46回米国血液学会, Dec. 2004, English, 米国血液学会, サンディエゴ, International conferenceGalactocerebrosides, essential for hematopoietic progenitor mobilization, regulate SDF-1 (CXCL12)-mediated attraction to boneOral presentation
- 第45回米国血液学会, Dec. 2003, English, 米国血液学会, サンディエゴ, International conferenceThe Integrin alpha4beta7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into the bone marrow following transplantationOral presentation
- International Society for Experimental Hematology
- 日本造血細胞移植学会
- 日本骨免疫学会
- 日本骨代謝学会
- American Society of Hematology
- 日本血液学会
- 日本内科学会
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B), Kobe University, 01 Apr. 2021 - 31 Mar. 2024Dynamism of spaciotemporal trafficking of hematopoietic stem/progenitor cells令和3年度までの研究で、骨髄赤芽球から産生される増殖因子(かつ一般的にはリン代謝ホルモンとして知られる)fibroblast growth factor-23 (FGF23)が高濃度で造血幹前駆細胞のFGF受容体に結合することにより、同細胞のケモカイン受容体CXCR4からのシグナルを抑制してケモカインCXCL12による細胞係留作用を断ち切ることで、造血幹前駆細胞が骨髄から遊離しやすくなることを確認した。この際、FGF23の結合は細胞表面上のCXCR4の発現強度やCXCL12蛋白の結合強度には全く影響を与えておらず、ほぼ細胞内シグナルの変化のみでその効果を発揮していた。また、食餌中のω3脂肪酸、特にeicosapentaenoic acid (EPA)が骨髄幼若好中球の受容体型転写因子PPARδのリガンドとして働き、骨髄血管透過性抑制因子angiopoietin-like protein 4(Angptl4)を産生させ、骨髄から造血幹前駆細胞の末梢血への動員を抑制していることも確認した。これらの知見は、骨髄有核細胞の大部分を占める骨髄球系細胞と赤芽球系細胞が、それらの親とも言える造血幹細胞の位置的運命制御を強力に行なっていることを示している。令和4年度にはこれらの機構が骨髄異形成症候群や骨髄増殖性疾患モデルでの病態形成に寄与しているかどうかを検討する予定である。 これらに加えて、血管内皮細胞に強く発現し、造血細胞動員時に骨髄球系細胞で発現が変化することを我々独自に捉えている分子 adrenomedullin(Adm)について、全身性ノックアウトマウスとfloxマウスを令和3年度に作成した。令和4年度には、造血幹前駆細胞の移動メカニズムにおけるAdmの作用についてもこれら新たなマウスモデルを用いて検討を進めていく。
- 科学研究費補助金/基盤研究(B), Apr. 2018 - Mar. 2021, Principal investigatorCompetitive research funding
- 学術研究助成基金助成金/挑戦的研究(萌芽), Apr. 2017 - Mar. 2019, Principal investigatorCompetitive research funding
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Kobe University, 01 Apr. 2015 - 31 Mar. 2018Transformed follicular lymphoma (TFL) predicts outcome in advanced endometrial cancerBackground: Transformed follicular lymphoma (TFL) was identified, as a candidate tumor suppressor gene that contributes to cell-cycle arrest through regulation of Rb phosphorylation, but the clinical impact of TFL is unknown. The goal of this study was to evaluate the prognostic significance of TFL expression in advanced endometrial cancer. Results: There were 24 TFL-low cases (23.3%) and the 10- PFS and OS in these cases were lower than those for patients with normal TFL expression in univariate analysis (PFS, P = .003; OS, P = .106). In multivariate analysis, TFL status was a significant predictor for PFS (HR 2.76, 95% CI 1.45-5.28; P = .002) and OS (HR 1.94, 95% CI 0.91-4.11; P = .085). Among 41 ERα-low patients, 10-year PFS was significantly lower in 15 TFL-low cases (multivariate analysis, HR 4.70, 95% CI 1.68-13.20, P = .003). Conclusions: We identified TFL as a strong independent prognostic factor, regardless of ERα status.
- 科学研究費補助金/基盤研究(B), Apr. 2015 - Mar. 2018, Principal investigatorCompetitive research funding
- 科学研究費補助金/新学術領域研究, Apr. 2015 - Mar. 2017, Principal investigatorCompetitive research funding
- 学術研究助成基金助成金/挑戦的萌芽研究, Apr. 2015 - Mar. 2017, Principal investigatorCompetitive research funding
- 科学研究費補助金/新学術領域研究, Apr. 2013 - Mar. 2015, Principal investigatorCompetitive research funding
- 科学技術振興機構, 戦略的創造研究推進事業 個人型研究さきがけ, 2015, Principal investigatorさきがけ「骨を要とする多臓器恒常性維持機構の解明」Competitive research funding
- 戦略的創造研究推進事業 個人型研究さきがけ, 2014, Principal investigatorさきがけ「骨を要とする多臓器恒常性維持機構の解明」Competitive research funding
- 戦略的創造研究推進事業 個人型研究さきがけ, 2013, Principal investigatorさきがけ「骨を要とする多臓器恒常性維持機構の解明」Competitive research funding
- 戦略的創造研究推進事業 個人型研究さきがけ, 2012, Principal investigatorさきがけ「骨を要とする多臓器恒常性維持機構の解明」Competitive research funding
- 科学研究費補助金/基盤研究(B), 2011, Principal investigatorCompetitive research funding
- 科学研究費補助金/新学術領域研究, 2011, Principal investigatorCompetitive research funding
- 科学研究費補助金/基盤研究(C), 2009Competitive research funding
- 科学研究費補助金/特定領域研究, 2008Competitive research funding
- 科学研究費補助金/萌芽研究, 2007Competitive research funding
- 科学研究費補助金/基盤研究(C), 2007, Principal investigatorCompetitive research funding
- 科学研究費補助金/若手研究(B), 2006, Principal investigatorCompetitive research funding